Home
>
US Stocks
>
Atea Pharmaceuticals Inc
Atea Pharmaceuticals Inc
AVIR

Atea Pharmaceuticals Inc (AVIR)

$12.7256.48%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
13.23
Today Low/High
12.29 / 13.23
52 Week Low/High
$18.72 / $94.17
Market Cap
$2.38B

Company Details

Atea is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing therapies to address the unmet medical needs of patients with life-threatening viral diseases. Leveraging its deep understanding of antiviral drug development, nucleoside biology, and medicinal chemistry, the Company has built a proprietary purine nucleotide prodrug platform to develop novel product candidates to treat single stranded ribonucleic acid, or ssRNA, viruses, which are a prevalent cause of severe viral diseases. Currently, the Company is focused on the development of orally available, potent, and selective nucleotide prodrugs for difficult-to-treat, life-threatening viral infections, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, dengue virus, hepatitis C virus (HCV) infection, and respiratory syncytial virus (RSV).
Organisation
Atea Pharmaceuticals Inc
Employees
39
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Atea Pharmaceuticals Inc (AVIR) share price today?

Can Indians buy Atea Pharmaceuticals Inc (AVIR) shares?

How can I buy Atea Pharmaceuticals Inc (AVIR) shares from India?

Can Fractional shares of Atea Pharmaceuticals Inc (AVIR) be purchased?

What are the documents required to start investing in Atea Pharmaceuticals Inc (AVIR) stocks?

We are a SEBI registered investement advisor